BMS-863233

DB12357InvestigationalSmall molecule

BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.

Mechanism: Pharmacologically active on Cell division cycle 7-related protein kinase
Curator reviewed
Formula / weight: C₁₄H₁₂ClN₃O₂ · 289.717 g/mol (avg)
Code names: BMS-863233

Resolves to

Compound

Structure

InChIKeyJJWLXRKVUJDJKG-VIFPVBQESA-NSMILES[H][C@]1(CCCN1)C1=NC2=C(OC3=C2C=C(Cl)C=C3)C(=O)N1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-863233, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.